News / Events


Karlsruhe, Germany, August 1st, 2018 - ActeaVentures GmbH is pleased to welcome Stefan Fischer as Senior Consultant. 

Stefan will add more than 25 years of hands-on experience within the pharmaceutical and biotech industry to the ActeaVentures Team. He worked for big pharma (Global Alliance Director at Roche) and as CEO at biotech companies (Capsant, Mutabilis, FABPharma). In addition, he run his own consulting firm prior to joining ActeaVentures. 

Stefan successfully managed several M&A projects and executed numerous licensing deals in Europe, Asia and the US.

His focus at ActeaVentures will be on assisting life science companies with their licensing, partnering and M&A activities. 

Stefan holds a MSc. in Chemistry from the University of Bochum, Germany.

 “Stefan will add an impressive deal making and management expertise to our team.”, says Jürgen Parrisius, one of ActeaVentures’ Managing Partners. “We are very pleased to have him on board and we look forward to making his proven knowledge and skill set available to our clients.”

About ActeaVentures

ActeaVentures is a global business development advisory firm for the Life Sciences Industry with operations in Europe, Asia and the US. ActeaVentures offers its clients comprehensive services for licensing and M&A projects in Pharma, Biotech, Diagnostics and Medtech. ActeaVentures’ team consists of Senior Business Development professionals with strong track records in deal making, having successfully served big pharma, medium-sized and biotech companies. ActeaVentures GmbH ( is privately held and registered in Karlsruhe, Germany.